GDF15 and metabolic dysfunction-associated steatotic liver disease: Given the relationships of GDF15 with both the fatty liver and the advanced atherosclerotic profile, specifically with the number of particles VLDL and its cholesterol and triglyceride content, this stress-response cytokine may be involved in the underlying mechanisms linking both pathologies, although further molecular studies are warranted in order to fully clarify the causative role of GDF15 in the CV risk related to MASLD.